FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

34732411000001107: Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104991001000001118 Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109827801000001119 Fluoxetine 10mg tablets (Endo Ventures Ltd) 30 tablet 3 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Is a Fluoxetine 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has AMP Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Fluoxetine hydrochloride true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fluoxetine true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Fluoxetine 10mg tablets (Par Laboratories Europe Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance Fluoxetine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start